RSS-Feed abonnieren
DOI: 10.1055/s-0038-1661634
Aggregation of Washed Platelets from Non-Anticoagulated Human Blood Is Not Reversible
Publikationsverlauf
Received 06. März 1986
Accepted 08. Juli 1986
Publikationsdatum:
20. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198602/lookinside/thumbnails/10-1055-s-0038-1661634-1.jpg)
Summary
Most of the knowledge acquired on platelet function and biochemistry has been obtained from platelets prepared from blood anticoagulated with sodium citrate. Using washed platelets from human blood (PNB) to which no anticoagulants were added, we report on responses not observed with platelets prepared from citrate-anticoagulated blood. Native blood was passed rapidly (within 5 min of venepuncture) through a Sephadex G-25/G-50 column to remove divalent ions and thus prevent coagulation. Platelets were separated from the gel-filtered blood by differential centrifugation. Responses of PNB to thrombin, collagen, calcium ionophore, ristocetin, release of 14C-5hydroxytryptamine and p-thromboglobulin, and generation of thromboxane A2 were similar to those observed for citrated platelets. Comparison of PNB with thrombin-treated platelets, which demonstrate an increase of platelet factor 3 activity, a reduction of the adenylate energy charge and an impairment of clot retraction, indicated the absence of platelet activation. Unlike citrated platelets, however, aggregation of PNB in response to ADP was irreversible in the presence of Ca2+ and fibrinogen, even at concentrations as low as 0.2 μM ADP, with aggregation taking up to 25 times longer to reach the same extent of aggregation as for citrated platelets. PNB did not aggregate to epinephrine even in the presence of Ca2+ and fibrinogen. Sodium citrate impaired ADP-induced aggregation and clot retraction of PNB. Thus citrate affects platelet function and may cause changes resulting in the unphy-siological behaviour and responses of platelets.
-
References
- 1 White JG. Effects of ethylenediamine tetracetic acid (EDTA) on platelet structure. Scand J Haematol 1968; 5: 241-254
- 2 Peerschke EI, Grant RA, Zucker MB. Decreased association of 45Calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation. Br J Haematol 1980; 46: 247-256
- 3 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
- 4 Zucker MB, Grant RA. Nonreversible loss of platelet aggregability induced by calcium deprivation. Blood 1978; 52: 505-514
- 5 Grant RA, Zucker MB. EDTA-induced increase in platelet surface charge associated with the loss of aggregability. Assessment by partition in aqueous two-phase polymer systems and electrophoretic mobility. Blood 1978; 52: 515-523
- 6 Fujimura K, Phillips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem 1983; 258: 10247-10252
- 7 Lages B, Weiss HJ. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemostas 1981; 45: 173-179
- 8 Packham MA, Mustard JF. Normal and abnormal platelet activity. In Blood Platelet Function and Medicinal Chemistry Lasslo A. (ed.) pp 061-128 Elsevier Biomedical; New York: 1984
- 9 Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228: 1757-1765
- 10 Heptinstall S, Mulley GP. Adenosine diphosphate induced platelet aggregation and release reaction in heparinized platelet-rich plasma and the influence of added citrate. Br J Haematol 1977; 36: 565-571
- 11 Macfarlane DE, Walsh PN, Mills DC B, Holmsen H, Day HJ. The role of thrombin in ADP-induced platelet aggregation and release - a critical evaluation. Br J Haematol 1975; 30: 457-463
- 12 Scrutton MC, Egan CM. Divalent cation requirements for aggregation of human blood platelets and the role of the anti-coagulant. Thromb Res 1979; 14: 713-727
- 13 Aursnes I, Gjesdal K, Abildgaard U. Platelet aggregation induced by ADP from unsheared erythrocytes at physiological Ca2+-concentrations. Br J Haematol 1981; 47: 149-152
- 14 Hoffmann B, Till U, Hoffmann J, Leosche W, Spangenberg P, Ostermann G. Anticoagulant-free preparation of platelets from human native blood - a methodical and morphological report. Thromb Res 1980; 18: 149-158
- 15 Bowry SK, Müller-Berghaus G. Properties of anticoagulant-free platelets: citrate inhibits platelet aggregation induced by ADP or thrombin. Blood 1984; 243: 281 (Abstr)
- 16 Bowry S. Sodium citrate impairs the function of anticoagulant-free platelets. Thromb Haemostas 1985; 54: 245 (Abstr)
- 17 Farrugia A, Griffin B, Pepper D, Prowse C. Studies on the procurement of coagulation factor VIII: Selective precipitation of factor VIII with hydrophilic polymers. Thromb Haemostas 1984; 51: 338-342
- 18 Gerrard JM. Platelet aggregation and the influence of prostaglandins. Methods Enzymol 1982; 86: 647-654
- 19 Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF A. Generation of prothrombin-converting activity and the exposure of phosphatidyl-serine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
- 20 Macfarlane DE, Mills DC B. The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 1975; 46: 309-320
- 21 de Gaetano G, Bottechia D, Vermylen J. Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thromb Res 1973; 2: 71-79
- 22 Hashimoto S. Functional pool of cyclic adenosine 3’5’-monophosphate in rabbit platelets. Thromb Haemostas 1983; 49: 08-12
- 23 Kaplan KL, Nossel HL, Drillings M, Lesznik G. Radioimmunoassay of platelet factor 4 and β-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol 1978; 39: 129-146
- 24 Kaplan KL, Broekman MJ, Chernoff A, Lesznik GR, Drillings M. Platelet α-granule proteins: studies on release and subcellular localisation. Blood 1979; 53: 604-618
- 25 Zucker MB. Proteolytic inhibitors, contact and other variables in the release reaction of human platelets. Thromb Diath Haemorrh 1972; 28: 393-407
- 26 Holmsen H, Day HJ, Setkowsky CA. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochem J 1972; 129: 67-82
- 27 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204
- 28 Ardlie NG. Calcium ions, drug action and platelet function. Pharmacol Thera 1982; 18: 249-270
- 29 Lasslo A, Quintana RP. Interaction dynamics of blood platelets with medicinal agents and other entities. In Blood Platelet Function and Medicinal Chemistry Lasslo A. (ed.) pp 229-315 Elsevier Biomedical; New York: 1984
- 30 Marcus AJ. Platelet aggregation. In Haemostasis and Thrombosis Colman RW, Hirsh J, Marder VJ, Salzmann EW. (eds.) pp 380-389 J. B. Lipineott Company; Philadelphia: 1982
- 31 Weiss HJ. Platelets: pathophysiology and antiplatelet drug therapy. pp 13-27 Alan R. Liss Inc; New York: 1982
- 32 Walsh PN, Mills DC B, White JG. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol 1977; 36: 281-296
- 33 Glusa E, Markwardt F. Adrenaline-induced reactions of human platelets in hirudin. Haemostasis 1980; 9: 188-192